| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10172058 | Respiratory Investigation | 2013 | 7 Pages |
Abstract
Irinotecan monotherapy is effective for advanced NSCLC patients who have previously failed 2 or more treatment regimens.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology and Microbiology (General)
Authors
Nobumichi Matsubara, Makoto Maemondo, Akira Inoue, Osamu Ishimoto, Kana Watanabe, Tomohiro Sakakibara, Tatsuro Fukuhara, Naoto Morikawa, Masashi Tanaka, Shunichi Sugawara, Toshihiro Nukiwa,